Infectious complications in SLE after immunosuppressive therapies
Kang I, Park S. Infectious complications in SLE after immunosuppressive therapies. Current Opinion In Internal Medicine 2003, 2: 629-635. DOI: 10.1097/00132980-200302060-00015.Peer-Reviewed Original ResearchSystemic lupus erythematosusMannose-binding lectin variant allelesHigh-dose glucocorticoidsImmunosuppressive therapyLupus erythematosusInfectious complicationsMycophenolate mofetilImmunosuppressive drugsRisk factorsVariant allelesMannose-binding lectin deficiencyMajor organ involvementUse of steroidsCommon viral infectionsExtrinsic risk factorsStrong risk factorIncidence of infectionHerpes zosterOrgan involvementSerious infectionsLectin deficiencyErythematosusImmune responsePatientsViral infectionInfectious complications in SLE after immunosuppressive therapies
Kang I, Park S. Infectious complications in SLE after immunosuppressive therapies. Current Opinion In Internal Medicine 2003, 2: 629-635. DOI: 10.1097/00132980-200312000-00015.Peer-Reviewed Original ResearchSystemic lupus erythematosusMannose-binding lectin variant allelesHigh-dose glucocorticoidsImmunosuppressive therapyLupus erythematosusInfectious complicationsMycophenolate mofetilImmunosuppressive drugsRisk factorsVariant allelesMannose-binding lectin deficiencyMajor organ involvementUse of steroidsCommon viral infectionsExtrinsic risk factorsStrong risk factorIncidence of infectionHerpes zosterOrgan involvementSerious infectionsLectin deficiencyErythematosusImmune responsePatientsViral infection